|3.||Neoplasm Metastasis (Metastasis)
|4.||Teratoma (Teratoid Tumor)
|5.||Testicular Neoplasms (Testicular Cancer)
|1.||Sheinfeld, Joel: 19 articles (02/2015 - 11/2002)|
|2.||Foster, Richard S: 17 articles (12/2015 - 10/2002)|
|3.||Dalmau, Josep: 14 articles (09/2015 - 08/2005)|
|4.||Bosl, George J: 14 articles (02/2015 - 10/2003)|
|5.||Wu, Joseph C: 13 articles (01/2015 - 02/2006)|
|6.||Einhorn, Lawrence H: 12 articles (12/2015 - 10/2002)|
|7.||Motzer, Robert J: 12 articles (02/2015 - 10/2003)|
|8.||Ulbright, Thomas M: 11 articles (12/2012 - 09/2003)|
|9.||Beck, Stephen D W: 10 articles (12/2015 - 10/2002)|
|10.||Bihrle, Richard: 10 articles (11/2015 - 10/2002)|
|1.||Biological Tumor Markers (Tumor Markers)IBA
01/01/2014 - "Furthermore, serum tumor markers may be helpful for diagnosing mature cystic teratoma and its torsion and, thus, can lead to early surgical intervention. "
01/01/2009 - "The detection of their clinical manifestation, the analysis of imaging features and the serum levels of tumor markers are helpful in diagnosing intracranial teratomas. "
02/01/2009 - "The objective of this study was to evaluate the serum levels of tumor markers in patients with ovarian mature cystic teratomas. "
01/01/2009 - "The purpose of this study was to evaluate the clinical value of serum tumor markers in patients with ovarian mature cystic teratoma (MCT). "
01/01/2006 - "The objective of this study was to evaluate size, bilaterality, histopathologic origin, and the serum levels of some tumor markers in patients with mature cystic teratomas (MCTs) of the ovary. "
|2.||Cisplatin (Platino)FDA LinkGeneric
01/01/2011 - "However, up to 30% of patients diagnosed with metastatic nonseminomas do not achieve a durable remission, and in metastatic teratomas cisplatin-based treatment resistance has been observed. "
01/01/2009 - "However, up to 30% of patients diagnosed with metastatic nonseminomas do not achieve a durable remission, and in metastatic teratomas cisplatin-based treatment resistance has been observed. "
09/15/1993 - "Among the eight patients with immature teratomas, five were treated before the advent of cisplatin treatment (two children younger than 15 years were cured by surgery alone and three adults died within 7 months after operation). "
03/01/2002 - "Histological examination showed that 5 weeks after injecting cisplatin (3 mg/kg/week), primitive mesenchymal-like cells increased, and 10 weeks afterward cartilage and well-developed glands (teratoma) were apparent; at > 15 weeks afterward there were no EC cells visible. "
01/01/1997 - "We report an unusually short lived and asymptomatic episode of severe cisplatin-induced renal tubular salt wasting in a fit 41-year-old patient with malignant teratoma. "
07/01/2004 - "Although perinatal teratomas have a relatively low recurrence rate of 5%, close follow-up with imaging studies and serum alpha-fetoprotein determinations is is strongly recommended. "
11/15/1993 - "Imaging studies suggested an intrahepatic teratoma, but serum alpha-fetoprotein levels were extremely elevated. "
12/01/1990 - "Histological analysis revealed a malignant teratoma, also with alpha-fetoprotein-positive elements in the immunohistochemical study."
10/01/2015 - "The optimal cutoff values for diagnosing immature teratomas were 8 months of age, 23 ng/mL in AFP level, and 2.5 cm in size, with 100% sensitivity and 89.5% accuracy rates. "
09/01/2015 - "Most children with testicular teratoma presented painless scrotal mass with a sense of bearing down and with abnormal serum AFP in most cases. "
01/01/2004 - "This case demonstrates the efficacy of interferon alpha2beta therapy in certain instances of growing teratoma syndrome, even when the tumorous mass is initially quite large."
09/01/1995 - "Remission of recurrent mature teratoma with interferon therapy."
04/01/2015 - "[A case of growing teratoma syndrome; long-term control accomplished by systemic interferon therapy with adequate local therapies]."
01/01/2013 - "Interferon-α Treatment for Growing Teratoma Syndrome of the Testis."
04/01/2009 - "The still incompletely resected, growing mature teratoma was reduced with interferon. "
|5.||Etoposide (VP 16)FDA LinkGeneric
10/01/2014 - "Comparatively, the equivalent cell population without etoposide treatment demonstrated a greater incidence and size of teratoma formation. "
06/01/2000 - "In conclusion, etoposide decreased the immature tissue components of teratomas, while mature tissues remained unaffected. "
06/01/2000 - "The etoposide-treated 4-week teratomas, but not the 6-week teratomas, were significantly smaller than those in the corresponding control groups. "
06/01/2000 - "Effect of etoposide on experimental testicular teratoma in 129/SvJ mice."
04/15/1994 - "Mechanisms of resistance to VP-16 were monitored in a series of sublines of the human testicular teratoma cell line (SuSa) derived following exposure either to fractionated X-irradiation (DXR-10) or to VP-16 using pulsed 24-hr exposures (VP10) or continuous exposure conditions (VPC2, VPC3 and VPC4). "
11/09/2010 - "One patient without teratoma improved spontaneously along with disappearance of NMDAR antibodies. "
06/01/2015 - "Antibodies to NMDAR were positive in cerebrospinal fluid (CSF) and serum samples, and pelvic computed tomography detected a large ovarian teratoma. "
01/01/2015 - "Ovarian teratoma is the confirmed tumour associated with anti-NMDAR antibodies. "
01/18/2014 - "No stem-cell-related teratoma formed and no anti-donor antibodies developed. "
12/01/2013 - "The patient was found to have an ovarian teratoma and serum and cerebrospinal fluid NMDAR antibodies. "
|7.||Congenital diaphragmatic herniaIBA
01/01/2015 - "At 20 weeks of gestation, congenital diaphragmatic hernia and sacrococcygeal teratoma had been seen on ultrasound. "
11/01/2014 - "Congenital diaphragmatic hernia and lung masses, fetal teratoma, and intra-abdominal masses are discussed, with an emphasis on differential etiologies and on fundamental management considerations. "
05/01/2010 - "This case describes a contiguous mediastinal and retroperitoneal mature teratoma in a congenital diaphragmatic defect, a combination that is hitherto unreported in literature. "
07/01/2004 - "The capability of MR imaging to demonstrate the normal bowel with intraperitoneal anomalies (e.g., congenital diaphragmatic hernia, and sacrococcygeal teratoma) is emphasized. "
08/01/2003 - "Fetal surgery for lung lesions, congenital diaphragmatic hernia, and sacrococcygeal teratoma."
|8.||Genetic Markers (Genetic Marker)IBA
05/01/1990 - "These results suggests that most of the analyzed benign ovarian teratomas arose from germ cells after the first meiotic division by failure of meiosis II. Teratomas heterozygous for all tested markers may arise from failure of meiosis I. In addition, 21 cases were karyotyped and analyzed for centromeric chromosome markers to study the mechanism by which they were generated. "
09/15/2003 - "We compared the pattern of allelic loss using nine microsatellite DNA markers (D9S177, D9S303, D9S778, D9S171, D12S1015, D1S508, D2S156, D18S46, and D11S903) between the epithelial cells of the teratoma and the cells in the adjacent stroma. "
11/01/1999 - "Twenty-five human benign ovarian teratomas were typed with 45 microsatellite DNA markers and classified according to their genotypic features. "
04/01/1999 - "We conclude that potential pitfalls in genotyping of teratomas including meiotic recombination and host cell participation can be avoided by a microdissection-based approach in combination with a panel of genetic markers."
05/01/1990 - "DNA markers heterozygous in the host were completely heterozygous in two of the teratomas. "
|9.||Twin twin transfusion syndromeIBA
05/01/2004 - "Conditions of increased preload and afterload in the fetus, such as sacrococcygeal teratoma and twin-twin transfusion syndrome, result in unique and complex pathophysiological states. "
12/01/2011 - "The causes of fetal anemia in our cohort were alloimmunization (32), parvovirus infection (23), feto-fetal transfusion syndrome (9), sacrococcygeal teratoma (2) and cytomegalovirus infection (1). "
04/01/2002 - "The most common conditions for which in utero fetal surgery is also being considered are twin to twin transfusion syndrome, myelomeningocele, sacrococcygeal teratoma, cystic adenomatoid malformation of the lung with fetal hydrops and other monochorionic twin abnormalities (severe discordant birth defects or twin reversal arterial perfusion sequences). "
04/01/2010 - "Although the efficacy of intrauterine intervention has been clearly demonstrated for some conditions, such as twin to twin transfusion syndrome and twin reversal arterial perfusion, it is still to be determined as treatment of congenital diaphragmatic hernia, cardiac defects, lower urinary tract obstruction and sacrococcygeal teratoma. "
05/01/2003 - "Congenital diaphragmatic hernia (CDH), obstructive uropathy, twin-to-twin transfusion syndrome (TTTS), and sacrococcygeal teratoma have already been successfully treated using minimal access fetal surgical procedures. "
|10.||squamous cell carcinoma-related antigenIBA
05/15/2000 - "Transvaginal color Doppler ultrasonic characterization of benign and malignant ovarian cystic teratomas and comparison with serum squamous cell carcinoma antigen."
12/01/1995 - "The role of serum squamous cell carcinoma antigen in detecting degeneration of mature cystic teratomas at an early stage is considered."
06/01/1997 - "The preoperative squamous cell carcinoma antigen level was significantly higher in the patients with squamous cell carcinoma arising from mature cystic teratoma than in patients with mature cystic teratoma (P < .0001). "
07/01/1995 - "We attempted to assess the clinical utility of squamous cell carcinoma antigen (SCC) for detecting squamous cell carcinoma arising in mature cystic teratoma of the ovary. "
07/01/1995 - "Clinical evaluation of squamous cell carcinoma antigen in squamous cell carcinoma arising in mature cystic teratoma of the ovary."
|1.||Drug Therapy (Chemotherapy)
08/01/1994 - "This study demonstrates that there is a group of patients with relapsed teratoma who can be cured without the need for very high dose chemotherapy and autologous bone marrow rescue."
07/01/1999 - "One patient who underwent complete resection of a mediastinal malignant teratoma combined, received PVB chemotherapy on an adjuvant basis and remains alive and disease-free. "
01/01/1992 - "Excepting in situations of great urgency surgery usually follows chemotherapy and is used as follows: in patients who appear to be in complete remission but who have residual lesions which require eradication, and those with malignant tissue which is persisting or more often of a mature teratoma which may have a risk of progressing. "
05/01/2007 - "Based on this successful case, intensive fertility-preserving surgery followed by chemotherapy, even in advanced-stage immature teratomas of the ovary, may be effective in preserving the reproductive function of women with malignant immature teratomas of the ovary."
05/01/1980 - "The malignant teratoma undifferentiated (stage IV) received chemotherapy (cis-diamminodichloroplatinum) with good results. "
|2.||Lymph Node Excision (Lymph Node Dissection)
04/01/2007 - "Retroperitoneal lymph node dissection is an effective treatment for growing teratoma syndrome, providing excellent local control and a low risk of progression."
11/01/2015 - "Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection."
05/01/2015 - "Teratoma had greater residual masses and our classification correlated with the need for lymphadenectomy."
02/01/2012 - "To evaluate whether an aggressive surgical policy, which included vascular surgery with standard retroperitoneal lymph node dissection (RPLND), would be justified for managing bulky retroperitoneal growing teratoma syndrome (GTS). "
03/15/2009 - "Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection."
01/01/1984 - "Prognosis is best in teratoma which is cured by orchiectomy. "
01/01/2014 - "Inguinal radical orchiectomy is the traditional gold standard treatment for benign testicular teratoma in children. "
07/01/2002 - "Patients with mature (40 pts.) and immature (19 pts.) teratoma were cured by orchiectomy alone. "
01/01/1993 - "One patient had surgical excision of a mature teratoma in the ipsilateral iliac region 26 months after orchiectomy and is now disease-free without further treatment after 25+ months. "
11/01/2015 - "Later on, the patient underwent bilateral radical orchiectomy, with pathology reporting a synchronous bilateral testicular teratoma. "
11/01/1975 - "Radiotherapy seems most effective in the palliation of undifferentiated (embryonal) teratoma of the gonads and sacrococcygeal region in early childhood. "
01/01/2014 - "He had undergone radiotherapy for testicular teratoma 34 years previously. "
01/01/2010 - "Intracranial growing teratoma syndrome following radiotherapy--an unusually fulminant course."
05/01/2005 - "The authors present a case of malignant teratoma in a 35-year-old male who was treated with surgery and radiotherapy. "
07/01/2001 - "In patients after teratoma removal post-operative radiotherapy was indicated."
04/03/1993 - "The first case concerned an 8-year old girl who had a teratoma; she was treated by surgery and adjuvant chemotherapy; 4 years after the diagnosis she is still alive and in complete remission. "
07/01/1998 - "It is suggested that an international randomized trial for patients with incompletely resected high risk teratoma be initiated to evaluate the effect of adjuvant chemotherapy on specific end-points: 1) influence on relapse rate in general; 2) reduction of the proportion of malignant relapses; 3) avoidance of mutilating surgery."
05/01/2013 - "In newborns or infants suffering from congenital malformations associated with teratomas, definitive surgical correction, if indicated, must obviously be postponed to a proper time, especially in patients with multiple malformations or needing adjuvant chemotherapy, unless a complication arises or the repair cannot be delayed."
05/01/2013 - "The treatment indicated is early, complete exeresis, followed by a careful, extensive microscopic examination associated, if necessary, with adjuvant chemotherapy, that is indicated before surgery only in infiltrating primary malignant teratomas. "
01/01/2012 - "One immature mediastinal teratoma that recurred locally 7.5 years after the initial operation was excised and adjuvant chemotherapy instituted. "